These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20093930)

  • 1. Bayesian logic in statistical test control: application to coagulation factor VIII assay.
    Sobas F; Bellisario A; Tsiamyrtzis P; Lienhart A; Nougier C; Négrier C
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):289-95. PubMed ID: 20093930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the adequate number of internal quality control levels: the example of coagulation factor VIII assay.
    Sobas F; Mazliak L; Bellisario A; Lefranc M; Lienhart A; Nougier C; Négrier C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):433-7. PubMed ID: 18600095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the 12s rule and Bayesian approach for quality control: application to one-stage clotting factor VIII assay.
    Sobas F; Tsiamyrtzis P; Benattar N; Lienhart A; Négrier C
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):634-43. PubMed ID: 24686098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
    Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
    Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogenic assay of human coagulation factor VIII: statistical comparison of 2 working dilution procedures.
    Alonso C; Gonzalez A; Frutos G
    Pharmeur Sci Notes; 2005 Aug; 2005(1):31-8. PubMed ID: 17687892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices.
    Manco-Johnson MJ; Nuss R; Jacobson LJ
    J Lab Clin Med; 2000 Jul; 136(1):74-9. PubMed ID: 10882230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cap survey results for factor VIII assays (1977-1978).
    Kocoshis TA; Triplett DA
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):346-51. PubMed ID: 474513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogenic assay of human coagulation factor VIII: statistical comparison of 2 working dilution procedures (Pharmeuropa Scientific Notes 2005-1).
    Volkers P
    Pharmeur Sci Notes; 2006 Aug; 2006(1):51; author reply 51-2. PubMed ID: 17694648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Precision control of a single step determination of blood coagulation factor VIII in the plasma].
    Lutze G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(1):109-15. PubMed ID: 69567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg.
    Nordfang O; Ezban M; Dinesen B
    Thromb Haemost; 1985 Jun; 53(3):346-50. PubMed ID: 3931283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
    Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
    Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
    O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
    Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.